Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Wendy Osborne

Newcastle AuthorsTitleYearFull text
Dr Wendy Osborne
MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial2021
Dr Caroline Shrubsole
Dr Wendy Osborne
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort2021
Dr Matt Horan
Dr Wendy Osborne
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival2020
Dr Wendy Osborne
Professor Stephen O'Brien
De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial2019
Dr Toby Eyre
Dr Wendy Osborne
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma2018
Dr Wendy Osborne
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting2017
Leanne Cork
Corinne Hedgley
Dr Wendy Osborne
Gemma Gills
Ruth Bescoby
et al.
Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia2015
Dr Wendy Osborne
Professor Stephen O'Brien
Corinne Hedgley
Ruth Bescoby
SPIRIT 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed chronic myeloid leukaemia-2 year follow up2015
Professor Stephen O'Brien
Corinne Hedgley
Dr Wendy Osborne
SPIRIT 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed CML2014
Professor Stephen O'Brien
Corinne Hedgley
Lynn Alaily
Dr Wendy Osborne
Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML2014